Results 201 to 210 of about 156,396 (269)

Comparing three methodologies for network analysis of human [¹¹C]glyburide whole-body PET data: d-networks, s-networks, and ΔPCC networks. [PDF]

EJNMMI Res
Hellman AF, Clegg PS, Marie S, Tournier N, Tavares AAS.   +4 more
europepmc   +1 more source

Type 2 Lepra Reaction Following Antituberculosis Treatment Initiation in an Elderly Male With Coexisting Hansen's Disease: A Case Report. [PDF]

Respirol Case Rep
Villanueva CAG, Ortiz YRH, Mojica WP, Albay AB.   +3 more
europepmc   +1 more source

Deoxyribonucleic ccid synthesis in isolated chloroplasts and chloroplast extracts of maize [PDF]

, 1982
Zimmermann, Wolfgang
core  

Successful Conservative Management of Complicated <i>Brucella</i> Endocarditis. [PDF]

J Med Cases
Alhajri MM.
europepmc   +1 more source

A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination With Meropenem Plus Amoxicillin/Clavulanate Among Adults With Rifampicin-Resistant Pulmonary Tuberculosis. [PDF]

Clin Infect Dis
de Jager V, Mockeliunas L, You H, Simonsson USH, Collings T, Upton CM, Bezuidenhout JA, Gupte N, Dorman SE, Nuermberger E, Lamichhane G, Diacon AH, Dooley KE.   +12 more
europepmc   +1 more source

The Quantification of Drug Accumulation within Gram-Negative Bacteria. [PDF]

ACS Infect Dis
George A, Shivangi, Bozan A, Spencer K, Terlecky AJ, Ahn YM, Barnett PR, Kreiswirth BN, Freundlich JS.   +8 more
europepmc   +1 more source

Diagnosis and Therapeutic Challenges of Drug-Resistant Tuberculosis Infection After Kidney Transplantation: A Rare Case Report. [PDF]

Infect Drug Resist
Song C, Zhao CY, Huang XW, Mo CJ, Qiang HB, Lin XS, Huang ZT, Xie ZH, Zhu QD.   +8 more
europepmc   +1 more source

Rifampicin as monotherapy for infections caused by Staphylococcus aureus: considerations for not applying 'breakpoints in brackets'. [PDF]

J Antimicrob Chemother
Boyd SE, Wootton M, Howe RA, Livermore DM, Macgowan AP, Kahlmeter G.   +5 more
europepmc   +1 more source

Protocol of a comparative multicentric non inferiority clinical trial of WHO MBMDT with a new monthly chemotherapy regimen containing rifampicin, moxifloxacin and clarithromycin (RMC) on multibacillary patients from India. [PDF]

Trials
Darlong J, Nessa S, Singh I, Sengupta U, Devi R, Govindasamy K, Maximus N, Elkana V, Haldar A, Jose AM, Jayakumar S.   +10 more
europepmc   +1 more source

Glycine Composition and Ion Valency Tune Phase Behavior and Drug Encapsulation in Designer Peptide Condensates. [PDF]

ACS Appl Mater Interfaces
Veretnik S, Harris R, Lampel A.
europepmc   +1 more source